Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 8.42% | 419.05 | 0.0% | $8674.93m | |
| BNTX | BioNTech SE | 17.80% | 414.44 | 0.0% | $1709.63m | |
| NVAX | Novavax, Inc. | 18.69% | 223.81 | 79.8% | $898.59m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -0.92% | 10.72 | 0.7% | $749.37m | |
| AMGN | Amgen, Inc. | -6.46% | 228.31 | 1.3% | $524.03m | |
| BIIB | Biogen, Inc. | 0.03% | 338.10 | 1.7% | $451.97m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.23% | 199.59 | 1.9% | $424.11m | |
| GILD | Gilead Sciences, Inc. | -0.85% | 69.24 | 1.0% | $409.81m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.95% | 580.95 | 2.7% | $330.19m | |
| ILMN | Illumina, Inc. | 1.24% | 504.60 | 3.5% | $271.58m | |
| NTLA | Intellia Therapeutics, Inc. | 5.87% | 146.94 | 2.3% | $204.93m | |
| SGEN | Seagen Inc. | 3.17% | 163.21 | 5.8% | $137.56m | |
| CRSP | CRISPR Therapeutics AG | 2.63% | 124.61 | 0.6% | $137.02m | |
| TBIO | Translate Bio, Inc. | 0.48% | 37.85 | 3.3% | $134.82m | |
| EXAS | EXACT Sciences Corp. | 1.56% | 105.83 | 18.1% | $131.45m |
Company Profile
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, Aimovig, KANJINTI, EVENITY, AMGEVITA, AVSOLA, BLINCYTO, MVASI, Corlanor, Enbrel, EPOGEN, IMLYGIC, Kyprolis, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, Otezla, RIABNI, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.